Analysis of Reportable Segments
Cigna Group operates in 3 segments: Evernorth Health Services; Cigna Healthcare; and Other Operations.
Segment Profit Margin
Cigna Group, profit margin by reportable segment
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Evernorth Health Services | 3.46% | 4.20% | 4.37% | 4.41% | 4.62% |
| Cigna Healthcare | 7.99% | 8.75% | 9.04% | 8.08% | 9.80% |
| Other Operations | -1.09% | 16.11% | 22.10% | 22.29% | 11.44% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
An analysis of segment profit margins from 2020 to 2024 indicates a broad decline in operational profitability across the organization. While the magnitude of the decline varies by segment, every reporting area ended the period with a lower profit margin than its 2020 position. The data suggests a transition from a period of relative stability and peak profitability in the early 2020s to a more challenging margin environment by 2024.
- Evernorth Health Services
- A consistent downward trend is observed in the profit margins of this segment. From a high of 4.62% in 2020, the margin experienced a gradual and steady decline over the subsequent three years, culminating in a more pronounced drop to 3.46% by the end of 2024. This represents a steady erosion of profitability throughout the observed period.
- Cigna Healthcare
- This segment exhibited moderate volatility while maintaining higher absolute margins compared to Evernorth. Following an initial decrease from 9.80% in 2020 to 8.08% in 2021, a temporary recovery occurred in 2022 with a margin of 9.04%. However, a sequential decline followed in 2023 and 2024, with the period ending at 7.99%, reflecting an overall contraction in margin performance.
- Other Operations
- The most significant fluctuations are evident in this segment. Profit margins increased sharply from 11.44% in 2020 to a peak of 22.29% in 2021, remaining relatively stable through 2022. This was followed by a steep decline to 16.11% in 2023 and a final collapse to -1.09% in 2024. This trajectory indicates a complete reversal of profitability, moving from the highest performing segment in 2021 to a loss-making position by the end of 2024.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Segment Profit Margin: Evernorth Health Services
Cigna Group; Evernorth Health Services; segment profit margin calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Pre-tax adjusted income (loss) from operations | 7,001) | 6,442) | 6,127) | 5,818) | 5,363) |
| Adjusted revenues | 202,155) | 153,499) | 140,335) | 131,912) | 116,130) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 3.46% | 4.20% | 4.37% | 4.41% | 4.62% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Segment profit margin = 100 × Pre-tax adjusted income (loss) from operations ÷ Adjusted revenues
= 100 × 7,001 ÷ 202,155 = 3.46%
The Evernorth Health Services segment has experienced a period of substantial scale expansion accompanied by a progressive compression in operational profitability margins. While absolute earnings have increased annually, the rate of revenue growth has outpaced the growth of pre-tax adjusted income, resulting in a steady decline in the segment profit margin from 2020 through 2024.
- Revenue Trajectory
- Adjusted revenues demonstrated consistent and accelerating growth, rising from US$116,130 million in 2020 to US$202,155 million in 2024. The most significant expansion occurred between 2023 and 2024, with a revenue increase of approximately US$48,656 million, indicating a rapid scaling of operations.
- Pre-tax Adjusted Income Performance
- Pre-tax adjusted income from operations maintained a positive upward trend, increasing from US$5,363 million in 2020 to US$7,001 million in 2024. Although income has grown every year, the growth rate has been more moderate compared to the surge in adjusted revenues.
- Segment Profit Margin Analysis
- A continuous downward trend is observed in the segment profit margin, which decreased from 4.62% in 2020 to 3.46% in 2024. The most acute decline occurred in the final year of the period, where the margin dropped from 4.20% to 3.46%. This divergence between rising revenues and falling margins suggests that the recent growth in scale has been achieved through lower-margin revenue streams or has been offset by increased operational expenses.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Segment Profit Margin: Cigna Healthcare
Cigna Group; Cigna Healthcare; segment profit margin calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Pre-tax adjusted income (loss) from operations | 4,229) | 4,478) | 4,072) | 3,609) | 4,031) |
| Adjusted revenues | 52,914) | 51,205) | 45,036) | 44,652) | 41,135) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 7.99% | 8.75% | 9.04% | 8.08% | 9.80% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Segment profit margin = 100 × Pre-tax adjusted income (loss) from operations ÷ Adjusted revenues
= 100 × 4,229 ÷ 52,914 = 7.99%
The financial performance of the Cigna Healthcare segment between 2020 and 2024 is characterized by consistent revenue expansion coupled with fluctuating operational profitability, resulting in an overall compression of the segment profit margin.
- Revenue Growth Trajectory
- Adjusted revenues exhibited a steady upward trend over the five-year period, increasing from US$ 41,135 million in 2020 to US$ 52,914 million by 2024. A notable acceleration in growth occurred between 2022 and 2023, where revenues increased from US$ 45,036 million to US$ 51,205 million.
- Pre-tax Adjusted Income Volatility
- Operational income did not mirror the linear growth of revenues. Following a decline in 2021 to US$ 3,609 million, income recovered and peaked at US$ 4,478 million in 2023. However, 2024 saw a contraction in income to US$ 4,229 million, despite the segment reaching its highest revenue level during the observed period.
- Segment Profit Margin Compression
- The segment profit margin demonstrated volatility and a general downward trajectory. From a period high of 9.80% in 2020, the margin fell to 8.08% in 2021, partially recovered to 9.04% in 2022, and subsequently declined to 7.99% by 2024. This trend indicates that costs associated with revenue generation grew disproportionately to income, leading to the lowest margin of the five-year period in 2024.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Segment Profit Margin: Other Operations
Cigna Group; Other Operations; segment profit margin calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Pre-tax adjusted income (loss) from operations | (9) | 96) | 500) | 889) | 966) |
| Adjusted revenues | 828) | 596) | 2,262) | 3,989) | 8,446) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | -1.09% | 16.11% | 22.10% | 22.29% | 11.44% |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Segment profit margin = 100 × Pre-tax adjusted income (loss) from operations ÷ Adjusted revenues
= 100 × -9 ÷ 828 = -1.09%
The Other Operations segment has experienced a significant contraction in both operational scale and profitability between 2020 and 2024. The period is characterized by a precipitous decline in revenues and a transition from substantial pre-tax income to a net operational loss.
- Revenue Trajectory
- Adjusted revenues decreased sharply from US$ 8,446 million in 2020 to US$ 596 million in 2023, representing a contraction of approximately 93%. A slight recovery was noted in 2024, with revenues increasing to US$ 828 million, although the volume remains significantly lower than the levels observed at the start of the five-year period.
- Operational Income Trends
- Pre-tax adjusted income from operations exhibited a consistent downward trend, falling from US$ 966 million in 2020 to US$ 96 million in 2023. By December 31, 2024, the segment transitioned to an operational loss of US$ 9 million, indicating that the segment's cost structure eventually exceeded its revenue generation capabilities.
- Profit Margin Analysis
- The segment profit margin demonstrated significant volatility. It initially rose from 11.44% in 2020 to a peak of 22.29% in 2021 and remained relatively stable at 22.10% in 2022. This initial expansion occurred despite falling revenues, suggesting a period of increased efficiency or the disposal of lower-margin assets. However, the margin declined to 16.11% in 2023 and ultimately collapsed to -1.09% in 2024, mirroring the erosion of pre-tax income.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Adjusted revenues
Cigna Group, adjusted revenues by reportable segment
US$ in millions
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Evernorth Health Services | 202,155) | 153,499) | 140,335) | 131,912) | 116,130) |
| Cigna Healthcare | 52,914) | 51,205) | 45,036) | 44,652) | 41,135) |
| Other Operations | 828) | 596) | 2,262) | 3,989) | 8,446) |
| Corporate and eliminations | (8,798) | (9,978) | (6,991) | (6,475) | (5,644) |
| Total | 247,099) | 195,322) | 180,642) | 174,078) | 160,067) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Total adjusted revenues demonstrate a consistent upward trajectory over the five-year period, with a significant acceleration in the final year. Total revenues increased from 160,067 million US dollars in 2020 to 247,099 million US dollars in 2024, representing a substantial expansion in the overall financial scale of operations.
- Evernorth Health Services Growth
- This segment serves as the primary driver of overall revenue expansion, exhibiting a continuous increase from 116,130 million US dollars in 2020 to 202,155 million US dollars in 2024. A notable surge is observed between 2023 and 2024, where revenues grew by approximately 32%, indicating a rapid scaling of this business unit.
- Cigna Healthcare Trends
- A steady and positive growth pattern is evident in the Cigna Healthcare segment. Revenues rose from 41,135 million US dollars in 2020 to 52,914 million US dollars in 2024. Although the growth is consistent, the rate of increase is more moderate than that of the Evernorth segment.
- Other Operations and Corporate Eliminations
- A sharp downward trend is observed in Other Operations, which fell from 8,446 million US dollars in 2020 to 828 million US dollars in 2024, suggesting a strategic divestment or a diminishing role of this segment. Corporate and eliminations showed an increasing negative impact from 2020 through 2023, peaking at -9,978 million US dollars before moderating slightly to -8,798 million US dollars in 2024.
The revenue composition has shifted decisively, with Evernorth Health Services becoming an increasingly dominant portion of the total revenue mix. The divergence between the rapid growth in health services and the contraction of other operations indicates a strategic concentration of business activity within the core service segments.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Pre-tax adjusted income (loss) from operations
Cigna Group, pre-tax adjusted income (loss) from operations by reportable segment
US$ in millions
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Evernorth Health Services | 7,001) | 6,442) | 6,127) | 5,818) | 5,363) |
| Cigna Healthcare | 4,229) | 4,478) | 4,072) | 3,609) | 4,031) |
| Other Operations | (9) | 96) | 500) | 889) | 966) |
| Corporate and eliminations | (1,688) | (1,698) | (1,466) | (1,339) | (1,552) |
| Total | 9,533) | 9,318) | 9,233) | 8,977) | 8,808) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The total pre-tax adjusted income from operations exhibited a consistent upward trajectory over the five-year period from 2020 to 2024, increasing from 8,808 million to 9,533 million. This steady growth reflects a resilient overall financial performance, primarily driven by the expansion of the largest business segment.
- Evernorth Health Services
- This segment demonstrates a strong and uninterrupted growth pattern, with pre-tax adjusted income rising every year from 5,363 million in 2020 to 7,001 million in 2024. It has evolved into the dominant contributor to the total operational income, representing a significant portion of the overall growth for the group.
- Cigna Healthcare
- The performance of this segment was characterized by moderate volatility. After a decline to 3,609 million in 2021, income recovered and reached a peak of 4,478 million in 2023, before experiencing a slight contraction to 4,229 million in 2024. Despite these fluctuations, the 2024 figures remain higher than the 2020 baseline of 4,031 million.
- Other Operations
- A sharp and continuous secular decline is observed in this segment. Income dropped from 966 million in 2020 to 96 million by 2023, ultimately transitioning into a loss of 9 million in 2024. This indicates a comprehensive erosion of profitability within this operational category over the analyzed period.
- Corporate and Eliminations
- Operational expenses and eliminations remained consistently negative, fluctuating within a range between -1,339 million and -1,698 million. The lack of a drastic increase in these costs relative to the growth in total income suggests a disciplined approach to corporate overhead management.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?